Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

11.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.0K
Protein-protein Interfaces02:04

Protein-protein Interfaces

14.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.4K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

983
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
983
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.8K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

11.5K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.5K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

7.3K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validation of a 2-Gene Blood Test for Kawasaki Disease in Febrile Children.

JAMA network open·2026
Same author

Deep learning for predicting patient drug response by transferring gene-level and cell-level knowledge to tumors.

NPJ precision oncology·2026
Same author

Effects of Maternal Tetramethyl Bisphenol F Exposure on Neurodevelopment and Behavior in Mouse Offspring.

International journal of molecular sciences·2026
Same author

Enacted practices and developmental experiences of senior medical student tutors in a structured peer tutoring program.

Korean journal of medical education·2026
Same author

Discovery of triazolyl azabicyclo[3.1.0]hexane derivative as an autotaxin inhibitors for the treatment of pulmonary fibrosis.

European journal of medicinal chemistry·2026
Same author

4-Hydroxyderricin from Angelica keiskei promotes the stability of BRCA1 in triple-negative breast cancer cells through inhibition of cathepsin S.

Phytochemistry·2026
Same journal

A Multi-Modal Framework for Phage-Host Interaction Prediction Using Multi-View Contrastive Learning.

IEEE transactions on computational biology and bioinformatics·2026
Same journal

Decoding Gene-Disease Associations with Computational Methods: A Survey.

IEEE transactions on computational biology and bioinformatics·2026
Same journal

A Competitive Coevolution-based Cancer Driver Pathway Identification Algorithm for Maximizing Coverage, Mutual Exclusivity, and Subnet Importance.

IEEE transactions on computational biology and bioinformatics·2026
Same journal

Prediction of GO Terms Based on Partitioning PPI Networks into Highly Connected Components.

IEEE transactions on computational biology and bioinformatics·2026
Same journal

Modeling and Tracking of Heterogeneous Cell Populations via Open Multi-Agent Systems.

IEEE transactions on computational biology and bioinformatics·2026
Same journal

Parameter Efficient Deep Learning Models for Multi-Target Binding Affinity and hERG Cardiotoxicity Prediction.

IEEE transactions on computational biology and bioinformatics·2026
See all related articles

Related Experiment Video

Updated: Jan 17, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.5K

EnsDTI: Predicting Drug-Target Interaction With Mixture-of-Experts and Confidence Assessment.

Yijingxiu Lu, Soosung Kang, Sun Kim

    IEEE Transactions on Computational Biology and Bioinformatics
    |January 14, 2026
    PubMed
    Summary
    This summary is machine-generated.

    EnsDTI enhances drug-target interaction (DTI) prediction by combining structure-based and ligand-based methods. This novel framework offers reliable predictions with confidence scores, improving drug discovery efficiency.

    More Related Videos

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
    07:51

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

    Published on: May 21, 2018

    12.5K
    Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
    10:21

    Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

    Published on: February 23, 2024

    3.7K

    Related Experiment Videos

    Last Updated: Jan 17, 2026

    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    19.5K
    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
    07:51

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

    Published on: May 21, 2018

    12.5K
    Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
    10:21

    Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

    Published on: February 23, 2024

    3.7K

    Area of Science:

    • Computational chemistry
    • Drug discovery informatics
    • Bioinformatics

    Background:

    • Accurate drug-target interaction (DTI) identification is crucial for efficient drug discovery.
    • Structure-based methods are accurate but computationally expensive for large chemical spaces.
    • Ligand-based methods lack consistency and reliability on unseen data.

    Purpose of the Study:

    • To develop a computational framework that balances speed and accuracy for DTI prediction.
    • To improve the reliability and applicability of DTI prediction tools in drug discovery.
    • To provide confidence scores for DTI predictions to aid in candidate filtering.

    Main Methods:

    • Proposed EnsDTI, a novel framework integrating structure-based and ligand-based DTI prediction approaches.
    • Utilized a mixture-of-experts architecture to leverage existing deep learning models for enhanced DTI predictions.
    • Incorporated an inductive conformal predictor to provide reliable confidence scores for predictions.

    Main Results:

    • EnsDTI demonstrated high performance in prediction accuracy across four benchmark datasets.
    • The framework achieved excellent confidence estimation capabilities.
    • Candidate rankings generated by EnsDTI showed strong correlation with actual docking affinities.

    Conclusions:

    • EnsDTI effectively bridges the gap between structure-based and ligand-based DTI prediction methods.
    • The framework offers a practical and reliable tool for ranking and filtering potential drug candidates in drug discovery.
    • EnsDTI's ability to provide confidence scores enhances its utility for efficient lead identification.